Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer (International Journal of Clinical Oncology, (2017), 22, 3, (494-504), 10.1007/s10147-016-1083-9)

Takeshi Suto, Megumi Ishiguro, Chikuma Hamada, Katsuyuki Kunieda, Hiroyuki Masuko, Ken Kondo, Hideyuki Ishida, Genichi Nishimura, Kazuaki Sasaki, Takayuki Morita, Shoichi Hazama, Koutarou Maeda, Hideyuki Mishima, Hideyuki Ike, Sotaro Sadahiro, Kenichi Sugihara, Masazumi Okajima, Shigetoyo Saji, Junichi Sakamoto, Naohiro Tomita

研究成果: Comment/debate査読

抄録

In the original publication of the article, Fig. 1 was published with incorrect numbers of patients (n). The correct Fig. 1 is given in this erratum.

本文言語English
ページ(範囲)805-806
ページ数2
ジャーナルInternational Journal of Clinical Oncology
22
4
DOI
出版ステータスPublished - 01-08-2017

All Science Journal Classification (ASJC) codes

  • 外科
  • 血液学
  • 腫瘍学

フィンガープリント

「Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer (International Journal of Clinical Oncology, (2017), 22, 3, (494-504), 10.1007/s10147-016-1083-9)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル